ENGN

Engene Therapeutics INC

-$2.1M

Net Activity

Institutions Holding

1

Popularity Rank

#6335

Avg Weight

0.03%

Total Value

$260.4K

Ownership Trend

1 institutions currently hold ENGN, with 1 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q2 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

1

Key Holders

View all 1 holding institutions

Quarterly Activity

Recent Activity

+$260.4K

Total Buy Value

$0.0

Total Sell Value

New buy1
Trim0
Add0
Sold out0

1

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

enGene Therapeutics Inc. (ENGN) announced on July 15, 2026 that Dr. Richard Glickman resigned as chairman and director, effective immediately. The company stated the resignation was not due to any disagreement. The board thanked him for his many years of service.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ENGENE THERAPEUTICS INC (ENGN)?
Major stakeholders currently include Marquette Asset Management, LLC ($260.4K). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in ENGN.
What is the overall institutional sentiment toward ENGN recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $2.1M, driven by 1 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their ENGN positions?
In the latest period, no tracked funds trimmed or exited their positions in ENGN.
Are there any notable investors adding ENGN to their portfolios?
Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $260.4K.

Related Stocks